The SGIV infected GE cells and growth medium were harvested at 72 h.p.i. and 23 centrifuged at 12,000 × g for 30 min at 4℃. The resulting pellet was resuspended with the 24 culture medium and ultrasonicated. The suspension containing the lysate, viral particles 25 and cellular debris were then centrifuged at 4,000 × g for 20 min at 4℃. The supernatant 26 was layered onto a cushion of 35% sucrose and centrifuged at 210,000 × g for 1 h at 4℃.
thickness were transferred to formvar carbon grids (on ice) using a drop of a mixture 50 containing 2 parts of 2.3M sucrose: 1 part of 2% methylcellulose. Grids with thawed 51 sections were incubated in 0.12% glycerin in PBS for 15 min, blocked with 1% BSA in 52 PBS for 30 min and washed 3 times with PBS, 5 min each. Sections were incubated in 53 primary antibodies for 1h (anti ORF075 Ab or anti His-tag Ab, 50× dilution) and then 54 washed 3 times with PBS, 5 min each. Secondary gold antibodies were added and 55 incubated for 1h (goat anti rabbit gold, EMS-25115 or goat anti mouse gold, EMS-25132, 56 40× dilution) and then washed 6 times with PBS, 5 min each. After that, grids were 57 fixed with 1% GA in PBS for 5 min, then washed 4 times with water, 5 min each. Finally, 58 grids were incubated with a mixture of 1 part of 1% UA: 9 parts of 2% methylcellulose, 59 on ice for 5 min. Grids were dragged on filter paper to remove the excess liquid and air 60 dried before TEM viewing.
Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Analyses of Control

62
Viruses and ORF75R-Knockdown Viruses
63
Purified control virions (100 µg) and ORF75R-knockdown virions (100 µg) were 64 dissolved in 10µl urea (10 M) separately at RT. Each sample was incubated with 2 µl 65 tris-(2-carboxyethyl) phosphine (TCEP, 100 mM stock solution) for 1h, and then 2 µl 66 methyl methane-thiosulfonate (MMTS, 200 mM stock solution) was added into each 67 sample for another 10min at RT. Following reduction and alkylation, trypsin (12.5 ng/µl, 68 Promega) was added and incubated at 37°C overnight. The digested peptides from 69 control virion and ORF75R knockdown virion were equally divided into two parts 70 separately for iTRAQ labeling. iTRAQ labeling was performed using the iTRAQ 71 Reagent kit (AB SCIEX, Foster City, CA, USA) following manufacturer's instructions.
72
To remove interfering substances, the pooled iTRAQ-labelled peptides was subjected to 73 strong cation exchange chromatography (SCX) using the iTRAQ Methods Development 74 Kit (AB SCIEX, Foster City, CA, USA). The bound peptides were eluted with 5% 75 ammonium hydroxide (NH 4 OH) in 30% methanol. They was desalted using a Sep-Pak 
